Related Experiment Video

Updated: Aug 25, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

514

PI3K and AKT at the Interface of Signaling and Metabolism

Giovanni Solinas1, Barbara Becattini2

  • 1The Wallenberg Laboratory for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, University of Gothenburg, 41345, Göteborg, Sweden. giovanni.solinas@wlab.gu.se.

Current Topics in Microbiology and Immunology
|October 15, 2022
PubMed

Insights

The PI3K/AKT pathway is crucial for metabolic homeostasis and immune responses. Understanding its specific roles and isoform functions is key to developing effective PI3K-targeted therapies for diseases like cancer and diabetes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Signaling

Background:

  • The PI3K/AKT signaling pathway regulates tissue and metabolic homeostasis, as well as immune responses.
  • Aberrant PI3K/AKT signaling is linked to cancer, diabetes, and growth defects, highlighting its critical role in health and disease.

Purpose of the Study:

  • To elucidate the role of PI3K/AKT signaling in insulin signaling and metabolic homeostasis.
  • To explore the interplay between insulin action, metabolic feedback loops, and resistance to PI3K-targeted therapies.
  • To investigate insulin-independent roles and isoform-specific functions of PI3K/AKT in metabolic regulation.

Main Methods:

  • Literature review and synthesis of existing research on PI3K/AKT signaling.
  • Analysis of the molecular mechanisms underlying PI3K/AKT's involvement in metabolic homeostasis.
  • Discussion of therapeutic strategies targeting PI3K/AKT pathways.

Main Results:

  • PI3K/AKT signaling is integral to insulin action and metabolic homeostasis.
  • Metabolic feedback loops can induce resistance to PI3K-targeted therapies.
  • PI3K/AKT exhibits both insulin-dependent and independent roles in metabolism.

Conclusions:

  • Defining the specific functions and redundancies of PI3K isoforms is essential for developing novel PI3K-targeted therapies.
  • Targeting PI3K/AKT requires careful consideration of its broad roles in systemic metabolism to avoid adverse effects.
Keywords:
CancerDiabetesGrowthImmunometabolismInsulinMetabolic InflammationObesity

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.1K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.3K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.1K